These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12941372)

  • 1. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport.
    Aubrey KR; Vandenberg RJ
    Br J Pharmacol; 2001 Dec; 134(7):1429-36. PubMed ID: 11724748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
    Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
    J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.
    Atkinson BN; Bell SC; De Vivo M; Kowalski LR; Lechner SM; Ognyanov VI; Tham CS; Tsai C; Jia J; Ashton D; Klitenick MA
    Mol Pharmacol; 2001 Dec; 60(6):1414-20. PubMed ID: 11723250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes.
    Herdon HJ; Godfrey FM; Brown AM; Coulton S; Evans JR; Cairns WJ
    Neuropharmacology; 2001 Jul; 41(1):88-96. PubMed ID: 11445189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons.
    Lim R; Hoang P; Berger AJ
    J Neurophysiol; 2004 Oct; 92(4):2530-7. PubMed ID: 15175365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
    Chen L; Muhlhauser M; Yang CR
    J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GlyT1 Inhibitor NFPS Exerts Neuroprotection via GlyR Alpha1 Subunit in the Rat Model of Transient Focal Cerebral Ischaemia and Reperfusion.
    Huang B; Xie Q; Lu X; Qian T; Li S; Zhu R; Yu W; Chen G; Chen Z; Xu X; Wang T; Li L
    Cell Physiol Biochem; 2016; 38(5):1952-62. PubMed ID: 27161043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
    Wu ZL; O'Kane TM; Connors TJ; Marino MJ; Schaffhauser H
    Brain Res; 2008 Aug; 1227():42-51. PubMed ID: 18621031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.
    Huang H; Barakat L; Wang D; Bordey A
    J Physiol; 2004 Nov; 560(Pt 3):721-36. PubMed ID: 15331688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC; Hashim A; Sershen H
    Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
    Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
    Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist.
    Zhang HX; Lyons-Warren A; Thio LL
    Neuropharmacology; 2009; 57(5-6):551-5. PubMed ID: 19619564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter.
    Lowe JA; Drozda SE; Fisher K; Strick C; Lebel L; Schmidt C; Hiller D; Zandi KS
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1291-2. PubMed ID: 12657266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels.
    Raiteri L; Stigliani S; Siri A; Passalacqua M; Melloni E; Raiteri M; Bonanno G
    Biochem Pharmacol; 2005 Jan; 69(1):159-68. PubMed ID: 15588724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity.
    Pinto MC; Lima IV; da Costa FL; Rosa DV; Mendes-Goulart VA; Resende RR; Romano-Silva MA; de Oliveira AC; Gomez MV; Gomez RS
    Neuropharmacology; 2015 Feb; 89():274-81. PubMed ID: 25312280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a scintillation proximity assay for analysis of Na+/Cl- -dependent neurotransmitter transporter activity.
    Williams JB; Mallorga PJ; Lemaire W; Williams DL; Na S; Patel S; Conn PJ; Pettibone DJ; Austin C; Sur C
    Anal Biochem; 2003 Oct; 321(1):31-7. PubMed ID: 12963052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.